| J9271 | Injection, pembrolizumab, 1 mg | 11,000 | $40 | $473K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 460 | $170 | $77.5K |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,590 | $40 | $58.8K |
| J0897 | Injection, denosumab, 1 mg | 1,560 | $20 | $28.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $140 | $27.1K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,000 | $30 | $26K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 120 | $200 | $22.9K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,030 | $20 | $22.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 200 | $110 | $22.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 100 | $130 | $13.1K |